Ravi Misra
Stock Analyst at Truist Securities
(0.70)
# 4,093
Out of 5,152 analysts
10
Total ratings
50%
Success rate
-11.87%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Hold | $120 → $135 | $117.57 | +14.83% | 2 | Dec 18, 2025 | |
| IART Integra LifeSciences Holdings | Reiterates: Hold | $15 → $13 | $9.89 | +31.45% | 1 | Nov 3, 2025 | |
| TDOC Teladoc Health | Downgrades: Hold | $42 → $35 | $5.12 | +583.59% | 2 | Aug 2, 2022 | |
| ALGN Align Technology | Upgrades: Buy | $683 | $175.60 | +288.95% | 3 | Apr 22, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $65 | $2.59 | +2,409.65% | 1 | Sep 15, 2020 | |
| GKOS Glaukos | Upgrades: Buy | $65 | $112.10 | -42.02% | 1 | Jan 6, 2020 |
Teleflex
Dec 18, 2025
Maintains: Hold
Price Target: $120 → $135
Current: $117.57
Upside: +14.83%
Integra LifeSciences Holdings
Nov 3, 2025
Reiterates: Hold
Price Target: $15 → $13
Current: $9.89
Upside: +31.45%
Teladoc Health
Aug 2, 2022
Downgrades: Hold
Price Target: $42 → $35
Current: $5.12
Upside: +583.59%
Align Technology
Apr 22, 2021
Upgrades: Buy
Price Target: $683
Current: $175.60
Upside: +288.95%
Nano-X Imaging
Sep 15, 2020
Initiates: Buy
Price Target: $65
Current: $2.59
Upside: +2,409.65%
Glaukos
Jan 6, 2020
Upgrades: Buy
Price Target: $65
Current: $112.10
Upside: -42.02%